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Abstract
Background: To determine the prevalence of human enteroviruses (HEVs) among healthy children, their parents,
and children with hand, foot, and mouth disease (HFMD).
Methods: We conducted a case–control study that included throat samples from 579 children with HFMD and
from 254 healthy controls. Throat samples from 49 households (98 parents and 53 healthy children) were also
analyzed. Phylogenetic analysis was carried out to study genetic relationships of EV71 strains.
Results: The HEV positive rate in HFMD patients was significantly higher than that in healthy controls (76.0% vs.
23.2%, P < 0.001). The EV71 (43.7% vs. 15.0%, P < 0.001), CVA16 (18.0% vs. 2.8%, P < 0.001), and CVA10 (5.7% vs. 0.8%,
P = 0.001) serotypes were significantly overrepresented in HFMD patients in comparison to healthy children. Other
HEV serotypes were detected with comparable frequency in cases and controls. The HEV positive rate in severe
HFMD patients was significantly higher than that in mild group (82.1% vs. 73.8%, P = 0.04). The EV71 (55.0% vs.
39.7%, P = 0.001) and CVA16 (11. 9% vs. 20.0%, P = 0.024) positive rate differed significantly between severe and mild
HFMD patients. Other HEV serotypes were detected with comparable frequency between severe and mild HFMD
patients. Among 49 households, 22 households (44.9%) had at least 1 family member positive for HEV. Children had
significantly higher HEV positive rate than adult (28.3% vs. 14.3%, P = 0.037). The HEV positive rate was similar
between mothers and fathers (12.24% vs. 16.32%, P = 0.56). The VP1 sequences of EV71 from HFMD patients and
healthy children were nearly identical and all were clustered in the same clade, C4a.
Conclusions: Our study demonstrated the co-circulation of multiple HEV serotypes in children with and without
HFMD during epidemic. Our study deserves the attention on HFMD control.
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Background
Enteroviruses (EVs) are among the most common human
viruses infecting humans, causing a wide spectrum of
illness. On the basis of phylogenetic analysis, the genus
Enterovirus (family Picornaviridae) is divided into 12 spe-
cies (www.picornaviridae.com). Members of human entero-
viruses (HEVs) include 7 species, four HEV species and 3
recently subsumed human rhinoviruses species. Although
infections caused by HEVs are often asymptomatic or mild,
they can cause more severe conditions, such as neurological
disease, poliomyelitis, severe neonatal systemic disease,
encephalitis, meningitis, or myocarditis.
Hand, foot, and mouth disease (HFMD) is a common
disease caused by HEV infection among children, particu-
larly in those less than 5-year-old. HFMD occurs worldwide
epidemically, with enterovirus 71 (EV71) and coxsackie-
virus A16 (CVA16) taking predominant roles in causing
outbreak, while other HEV serotypes were largely associ-
ated with sporadic cases. In the past decade, the size and
frequency of HFMD outbreaks have greatly increased in
the Asia-Pacific region, especially in Southeast Asia [1,2].
In China, a large scale outbreak of HFMD emerged in
2007 in Shandong Province, with 1149 cases reported
[3]. The nationwide epidemics of HFMD started in 2008 in
Anhui province, with approximately 490,000 cases reported
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[4]. Since then, there has been a large outbreak of HFMD
annually in China. In 2012, the Chinese Center for Disease
Control and Prevention (China CDC) confirmed 2,168,737
cases in Mainland China including 569 deaths (published
on the website of the Ministry of Health of China). HFMD
has become an important public health issue in China.
Since HFMD was classified as a category C notifiable
infectious disease by the Ministry of Health of China in
2008, the laboratory detection of EV71 and CVA16 has
been routinely performed in pediatric sentinel sites set
by the Infectious Disease Surveillance Center for HFMD
patients. This allowed an extensive epidemiological and
genetic characterization of the EV71 and CVA16 infection
nationwide. However, the negative detection of EV71 and
CVA16 had been reported frequently in China [5-7]. In
few studies, other HEV serotypes were investigated, and
suggested that CVA10, CVA6, CVA4 and CVA12 were as-
sociated with sporadic HFMD cases [6,7]. However, none
of the aforementioned studies could ascertain their causal
associations with HFMD development or disease severity
of HFMD; due to lack of a four-fold antibody titer increase
in convalescent samples, or make any comparison with
healthy subjects. In addition, most previous data on HEV
circulation have been reported from analysis of specimens
from patients [7,8], whereas little epidemiologic informa-
tion is available for the HEV circulation in healthy popula-
tion, especially in China [9-11]. To address this query, a
designed case–control study was performed to identify the
HEV circulation in children with and without HFMD.
Household distribution of HEVs was also investigated
to disclose the epidemiologic characteristics of house-
hold distribution of HEVs in the healthy population.
Methods
Sample collection
The case–control study was performed in Jining city in
Shandong province from May to October 2010. The
children diagnosed as HFMD in Jining city were re-
cruited into the study in the sentinel hospitals set by
the national surveillance program for HFMD in Shandong
province. The patients were identified according to the
diagnostic criteria defined by the Ministry of Health
(http://www.moh.gov.cn/publicfiles/business/htmlfiles/
mohyzs/s3586/201004/46884.htm). Children with serious
complications, including encephalitis, meningitis, acute
flaccid paralysis, cardiorespiratory failure of death, were
considered as severe HFMD. Children diagnosed as HFMD,
but without any of the above mentioned serious complica-
tions, were classified as mild HFMD. Medical records of
the HFMD patients were reviewed by physicians to collect
the demographic data, the clinical symptoms and signs,
laboratory findings, clinical diagnoses and outcomes.
Healthy children in Jining city were recruited as controls
during the same period when the cases were recruited. Four
villages that served as the sources of the patients in the
selected hospitals were randomly selected as study sites.
In each of two villages, one kindergarten was randomly
selected to recruit healthy children less than 5-year-old.
In other two villages, healthy children of less than 3-year-
old were randomly recruited from families. Throat swabs
were collected and personal information on demographic
factors and medical history were obtained from their
guardians by using a standard questionnaire. Throat swabs
from parents who took care of healthy children and were
willing to participate into the study in the two villages
were collected simultaneously when sampling children.
For the parents, personal information on demographic
factors and medical history were collected via a question-
naire. All the recruited healthy children and parents did
not exhibit HFMD-related symptoms before or at the time
of sample collection.
This study was performed with the approval of the
Ethical Committee of Beijing Institute of Microbiology
and Epidemiology and Jining Infectious hospital and was
conducted according to the principles expressed in the
Declaration of Helsinki. At recruitment, written informed
consent was obtained from all participants or guardians of
pediatric participants.
Detection and genotyping of HEV
For the detection of HEV, RNA were extracted from
each specimen by using QIAamp® MinElute Virus Spin
Kits (QIAGEN, Hilden, Germany) and the cDNA sample
was synthesized by using SuperScript® III First-Strand
Synthesis System for Reverse Transcription Polymerase
Chain Reaction (RT-PCR) (Invitrogen, America). The
detection of HEV and further classification of EV71 and
CVA16 for HEV-positive samples were performed by real-
time PCR using previously described primers, respectively
[12]. To further identify the HEV serotypes other than
EV71 and CVA16, semi-nested RT-PCR specific for a
5′ partial region of VP1 was performed for other HEV-
positive samples by using previously reported primers
[13]. The amplicons were subjected to sequencing and
BLAST analysis.
Sequence analysis of EV71
The VP1 sequences (891 bp) for EV71 positive samples
from healthy children and HFMD patients were amplified
by nested-PCR using primers (Table 1). The genomic se-
quences were assembled using Lasergene’s DNA SeqMan
software (version 7.1.0, DNA Star Inc. Madison, WI, USA).
The sequences obtained from the study were submitted to
NCBI with the GenBank Accession Numbers: KF704042-
KF704050, HQ668342, HQ668360, HQ668388, HQ668400,
and HQ668414-HQ668422. The MEGA program (version
5.05, Sudhir Kumar, Arizona State University) was used
for alignments and phylogenetic tree construction by
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neighbor-joining method or maximum likelihood method
with 1000 bootstrap pseudo replicates. Similarities between
strains were calculated by using BioEdit (version 7.13,
www.mbio.ncsu.eud/bioedit/bioedit.html).
Statistical analysis
Descriptive statistics were performed, with continuous
variables summarized as median and range, and categorical
variables summarized as frequencies and proportions. The
statistical significance of difference in HEV prevalence rates
between various groups was tested using the t test for
continuous variables and the χ2 test and Fisher’s exact
test for categorical data. Analyses were performed using
SPSS, version 11.5 (SPSS).
Results
Prevalence and serotypes of HEV in cases and controls
Altogether 579 HFMD patients were recruited into the
study, with age ranging from 4 to 97 months (median,
27.5 months) and 395 (68.2%) were males. Among all
the tested HFMD patients, 440 (76.0%) were infected
with HEV, among whom the frequency of HEVs in severe
HFMD patients was significantly higher than that in
mild disease group, 82.1% (124/151) vs. 73.8% (316/428)
(P= 0.04). Among 440 HEV positive samples from patients,
429 were successfully typed and 12 serotypes were iden-
tified: EV71 (253, 43.7%), CVA16 (104, 18.0%), CVA10
(33, 5.7%), CVA6 (22, 3.8%), CVA12 (6, 1.0%), echovirus
9 (3, 0.5%), echovirus 6 (2, 0.4%), CVB6 (2, 0.4%), CVA4
(1, 0.2%), CVA14 (1, 0.2%), echovirus 24 (1, 0.2%) and
echovirus 3 (1, 0.2%). Respectively eight and eleven se-
rotypes were determined from severe and mild HFMD
patients. The EV71 (55.0% vs. 39.7%, P = 0.001) and
CVA16 (11.9% vs. 20.0%, P = 0.024) positive rate differed
significantly between severe and mild HFMD patients. For
the rarely detected serotypes, CVA14 was only detected
from severe cases, while echovirus 3, echovirus 24, CVB6
and CVA4 were only detected from mild cases. The fre-
quencies of other five serotypes were evenly distributed
between the two groups (all P > 0.05). The detailed dis-
tribution of HEV serotypes in HFMD patients is shown
in Table 2.
In total, 254 healthy children were included as control
and had throat swabs collected. Their age ranged from 3
to 72 months (median: 48.0 month) and 136 (53.5%) were
male. Altogether 59 (23.2%) of 254 throat swabs were found
to be positive for HEV, and 56 HEV positive samples
were successfully typed. Eight serotypes were determined
with the most frequently presented serotypes as EV71
(38, 15.0%) and CVA16 (7, 2.8%), followed by CVA6
(4, 1.6%), CVA10 (2, 0.8%), echovirus 3 (2, 0.8%), echovirus
24 (1, 0.4%), echovirus 9 (1, 0.4%), and CVB6 (1, 0.4%).
In comparison with HFMD patients, the frequencies of
HEVs in healthy controls were significantly lower, 76.0%
(440/579) vs. 23.2% (59/254) (P < 0.001). The EV71 (43.7%
vs. 15.0%, P < 0.001), CVA16 (18.0% vs. 2.8%, P < 0.001),
and CVA10 (5.7% vs. 0.8%, P = 0.001) serotypes were sig-
nificantly overrepresented in HFMD cases in comparison
to healthy controls. The frequencies of other five serotypes
(CVA6, echovirus 3, echovirus 9, echovirus 24, CVB6)
were not significantly different between the two groups
(all P > 0.05). Four HEV serotypes (echovirus 6, CVA12,
CVA4 and CVA14) were only detected from HFMD cases,
while not from healthy controls.
Prevalence and serotypes of HEV among households
A total of 49 households involving 98 parents and 53
healthy children were recruited and sampled. The HEV
infection rate for all family members was 19.2% (29/151).
Children had significantly higher HEV infection rate than
adults (28.3% vs. 14.3%, P = 0.037). The HEV infection rates
were similar between mothers (12.24%; 6/49) and fathers
(16.32%; 8/49) (P = 0.56). Twenty-two households (44.9%)
had at least 1 family member with evidence of HEV infec-
tions, comprising seven serotypes: EV71 (11.92%), CVA16
(2.65%), CVA10 (1.32%), CVA6 (1.32%), echovirus 9 (0.66%),
echovirus 3 (0.66%), and CVA4 (0.66%). In four house-
holds, both children and parents were infected with HEVs,
although the virus serotypes involved were different
within each family. The remaining 18 households had
only children or parents with evidence of HEV infections.
Among them, 10 households had CVA16, CVA6, E3, EV71,
CVA10 infections in children, while 8 households had
EV71, CVA16, CVA10, and CVA4 infections in parents
(Table 3). There were 2 households (household 44 and 45)
where both father and mother had HEV infections, and the
same HEV serotype (EV71) was detected between father
and mother. Among 4 households which had two children,
Table 1 Primers used for enterovirus 71 VP1 sequencing by RT-PCR
Primer Sequence Position Usage
VP1-2382 F1 5′-ATAATAGCACTAGCGGCAGCCCA-3′ 2382 Nested RT-PCR, 1st round
VP1-2415 F2 5′-ACCATGAAGTTGTGCAAGGA-3′ 2415 Nested RT-PCR, 2st round
VP1-3387R2 5′-GCCCCAGACTGTTGTCCAAA-3′ 3387 Nested RT-PCR, 2st round
VP1-3478R1 5′-GTCGCGAGAGCTGTCTTCCCA-3′ 3478 Nested RT-PCR, 1st round
2833F 5′-GAGYTRTTCACCTACATGCG-3′ 2833 Sequencing
3065R 5′-CTCGCRGGTGACATGAAYGG-3′ 3065 Sequencing
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Table 2 Prevalences of enterovirus serotypes in children with and without hand, foot, and mouth disease
HFMD cases Healthy
children (n = 254)
P valueb
Severe HFMD Mild HFMD Severe HFMD
vs. mild HFMD
HFMD cases vs.
healthy children(n = 151) (n = 428)
HEV status
Negative 27 (17.9) 112 (26.2) 195 (76.8) 0.04 < 0.001
Positive 124 (82.1) 316 (73.8) 59 (23.2)
HEV serotypesa
EV71 83 (55.0) 170 (39.7) 38 (15.0) 0.001 < 0.001
CVA16 18 (11.9) 86 (20.0) 7 (2.8) 0.024 < 0.001
CVA10 11 (7.3) 22 (5.1) 2 (0.8) 0.33 0.001
CVA6 4 (2.7) 18 (4.2) 4 (1.6) 0.39 0.09
E3 0 1 (0.2) 2 (0.8) ND 0.17
E9 2 (1.3) 1 (0.2) 1 (0.4) 0.11 0.81
E24 0 1 (0.2) 1 (0.4) ND 0.55
CVB6 0 2 (0.5) 1 (0.4) ND 0.91
E6 1 (0.7) 1 (0.2) 0 0.44 ND
CVA12 2 (1.3) 4 (0.9) 0 0.68 ND
CVA4 0 1 (0.2) 0 ND ND
CVA14 1 (0.7) 0 0 ND ND
Untyped 2 (1.3) 9 (2.1) 3 (1.2) ND ND
aHFMD, hand, foot, and mouth disease; EV, enterovirus; CV, coxsackievirus; E, echovirus; NA; ND, not determined.
bFisher exact test or χ2 test.
Table 3 Circulation of enterovirus in healthy family members in Jining city, Shandong Province
No.(%) of
families (n = 49)
HEV status HEV serotypesa
Children Parents Households Child 1 Child 2 Father Mother
27 (55.1) Negative Negative 1-26 Negative — Negative Negative
27 (2 children) Negative Negative Negative Negative
10 (20.4) Positive Negative 28-36 EV71 (n = 3), CVA16 (n = 2), CVA6
(n = 2), CVA10 (n = 1), E3 (n = 1),
— Negative Negative
37 (2 children) EV71 EV71 Negative Negative
8 (16.3) Negative Positive 38 (2 children) Negative Negative EV71 Negative
39 (2 children) Negative Negative EV71 Negative
40 Negative — CVA4 Negative
41 Negative — Negative EV71
42 Negative — Negative EV71
43 Negative — Negative EV71
44 Negative — EV71 EV71
45 Negative — EV71 EV71
4 (8.2) Positive Positive 46 EV71 — CVA10 Negative
47 CVA9 — EV71 Negative
48 EV71 — CVA16 Negative
49 EV71 — Negative CVA16
aEV, enterovirus; CV, coxsackievirus; E, echovirus.
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siblings were all infected with EV71 in family 37, and
siblings were all negative for HEV in other 3 households
(households 27, 38 and 39).
Genetic characterization of EV71 circulating in healthy
children and HFMD patients
Among 38 EV71 positive specimens from healthy children,
half (n = 19) were randomly selected and 9 entire VP1
sequences were successfully amplified and sequenced.
Among 253 EV71 positive specimens from HFMD patients,
10% (n = 25) were randomly selected and 13 VP1 sequences
were successfully amplified and sequenced. The failure
to sequence EV71 VP1 in other specimens positive by
RT-PCR may be ascribed to low viral load. The phylo-
genetic tree was constructed with the VP1 nucleotide
sequences of both healthy children and HFMD patients
from the present study and those downloaded from
GenBank (Figure 1). All the sequenced EV71 strains in
the current study were classified as belonging to the
C4a group, demonstrating highest similarity with strains
from Shandong province. The EV71 strains identified
from healthy children and HFMD patients in this study
showed sequence identity of 97.1%-100%. In addition,
all isolates from members living in the same household
(households 44 and 45 where both husband and wife had
EV71 infection, and household 37 with all siblings infected
with EV71) had 100% sequence homology, suggesting a
possible interfamilial spread of this virus strain.
Discussion
In this study, we identified a variety of HEV genotypes
from throat swabs of HFMD patients in Jining, China.
Our results show a diversified pathogen composition which
is similar with reports from other areas of China [7,14-16],
Spain [17], Korea [18], India [19] and Singapore [20]. By
comparison between HFMD cases and healthy controls, we
found that EV71, CVA16, and CVA10 serotypes were more
frequently related to HFMD. In contrast, other five serotypes
(CVA6, echovirus 3, echovirus 9, echovirus 24, CVB6) were
detected in the two groups of subjects with comparable
frequency. Some HEV serotypes were only detected from
HFMD cases, and not from healthy controls. However,
their roles cannot be confirmed due to the small number
of positives found. In this study, CVA6 was detected in-
frequently whereas it has been associated with sporadic
HFMD cases and outbreaks occurred recently in Japan
[21], Spain [22], USA [23] and Thailand [24]. A study
performed in Taiwan in 2010 documented CVA6 as a
major cause of atypical HFMD, while CVA16 and EV71
were reported rarely [25]. In addition, we found that EV71
was overrepresented in severe HFMD patients, concurring
with previous studies showing extremely high circulations
of EV71 in more severe cases [26]. Our results also sup-
ported the notion that EV71 and CVA16 circulate widely
and actively in China as two main causative agents of
HFMD, as previously reported [6,27].
The aetiology of HFMD has changed with time occurred
in China and in several other countries [15,16,24]. The sen-
tinel surveillance studies performed in Linyi City, Shandong
province, China, showed that the pathogen spectrum chan-
ged from 2008 to 2011, with the most prevalent HEV sero-
type being EV71 between 2008 to 2010, and CVA16 in
2011 [4,15,28]. CVA6 replaced CVA16 as the second most
common serotype between 2010 to 2012 in Shenzhen,
China [16]. In Thailand, HFMD is usually caused by EV71
and CVA16, but an outbreak of HFMD in 2012 was
identified to be caused by CVA6 [24]. Considering that
the population of the present study was restricted tem-
porally and geographically, prolonged surveillance and
more detailed molecular-typing surveillance of HEVs are
needed to better understand the composite viral etiology
of HFMD in this area.
Our understanding of epidemiological and genetic
characteristics of HEV in the healthy population remains
far from complete. In recent years, several studies among
healthy individuals in different countries have shown di-
versity in HEV positive rates. Studies conducted among
children in Shenzhen, China [29] and Norway [10,30,31]
reported a HEV positive rate of 10.6 and 11.6% from stool
samples respectively. Isolation rates of 64% and 35% were
obtained from stool samples collected in children under
10-year-old and adults over 21-year-old in Mongolia [32].
With regard to EV71, diversity in positive rate has also been
reported among healthy individuals in different countries.
Han et al. reported positive rates of 0, 4.93 and 10.29% in
throat swabs and 2.86, 3.94 and 8.82% in stools from three
villages with different HFMD prevalence rate [9]. Studies
conducted among children in Finland [33] and Norway
[10,30,31] reported an EV71 positive rate of 0.3 and 1.4%
from stool samples respectively, and isolation rate of 1.8%
from stool samples were reported among children in
Shenzhen, China [29]. Herein we demonstrated that
23.2% and 15.0% out of 254 healthy children carried HEV
and EV71 respectively. This might represent the highest
EV71 detection rate reported this far among healthy
children. Our survey was performed during the local
HFMD epidemic period ranging from May to August,
which could partially explain the high EV71 frequency.
The differences in specimens sampled, selection of subjects,
and virus identification methods, as well as the climate,
geography, crowding, and socio-economic status factors
could also lead to the differences in the positive rate be-
tween our study and others.
EV71 is classified into three genotypes A, B and C,
and within the genotypes B and C, there are further
subgenotypes, B1-B5 and C1-C5. Recently, several studies
also proposed that subgenotype C4 strains should be des-
ignated as a new genotype D and that the B5 isolates to be
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re-designated as B4 [34,35]. In China, the C4 subgenotype
was identified as the most prominent circulating EV71 sub-
genotype [27]. All EV71 sequences reported in this study,
regardless of disease status, cluster within the C4a clade,
implying that C4a EV71strains predominated in Jining city
in 2010. The large numbers of asymptomatic persons who
carry HEVs, especially EV71, may serve as a reservoir for
transmission of HEV to children and contribute to the large
epidemics that occur annually.
Transmission of HEVs within a household is common.
A recent prospective family cohort study investigated
EV71 patients at a children’s hospital and family members
of these patients who had EV71 has reported that the
EV71 transmission rate to household contacts was 52%,
Figure 1 Phylogenetic trees were constructed from the VP1 nucleotide sequences of EV71 using neighbor-joining method with 1000
bootstrap by CLC genomics workbench. The tree was based on the 891 VP1 nucleotide sequences of EV71. The strains labeled with green
dots were obtained from healthy children in our study. The strains labeled with red dots were obtained from HFMD patients in our study.
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and the transmission rate from children to parents was
41% [36]. Kuramitsu et al. found that interfamilial spread
was responsible for 54% of non-polio HEV infections in
healthy persons [32]. Our family study showed that
18.5% of family members were positive for HEV, and
children had significantly higher HEV positive rate
than adults. Limited transmission between parents and
children was demonstrated, despite the inconsistent
positive detection and incongruent serotypes obtained.
Possible transmission between siblings and between
husband and wife was suggested, however, only in few
families. The information obtained in this study further
supported the potential transmission of HEVs even
among asymptomatic children, finally leading to a high
reservoir for future epidemic. Our study findings stress
the importance of personal hygiene to prevent infection
with HEVs in the home environment. However, because
of the limited number of families, further studies of larger
sample size are needed. In addition, prospective follow-up
of households would help clarify the distribution and
transmission of HEVs within a household.
Conclusions
In conclusion, this study demonstrated the co-circulation
of multiple HEV serotypes in both HFMD cases and
healthy children during HFMD epidemics. This study
provides useful epidemiological data on the features of the
spread of HEV among families as well. These findings have
important public health implication for HFMD control,
especially in HFMD high epidemic regions.
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